134 related articles for article (PubMed ID: 36332115)
21. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
[TBL] [Abstract][Full Text] [Related]
22. Leukocytoclastic vasculitis as early manifestation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Zoroquiain P; González S; Molgó M; Rodríguez A; Valbuena JR
Am J Dermatopathol; 2012 May; 34(3):330-4. PubMed ID: 22197862
[TBL] [Abstract][Full Text] [Related]
23. A rare case of Epstein-Barr virus-positive mucocutaneous ulcer that developed into an intestinal obstruction: a case report.
Morita N; Okuse C; Suetani K; Nakano H; Hiraishi T; Ishigooka S; Mori S; Shimamura T; Asakura T; Koike J; Itoh F; Suzuki M
BMC Gastroenterol; 2020 Jan; 20(1):9. PubMed ID: 31931725
[TBL] [Abstract][Full Text] [Related]
24. Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's disease.
Moran NR; Webster B; Lee KM; Trotman J; Kwan YL; Napoli J; Leong RW
World J Gastroenterol; 2015 May; 21(19):6072-6. PubMed ID: 26019475
[TBL] [Abstract][Full Text] [Related]
25. A Kidney Transplant Recipient With a Perforated Cheek: Oral Epstein-Barr Virus-Positive Mucocutaneous Ulcer Complicated With an Opportunistic Bacterial Infection.
Eleftheriadis T; Rountas C; Golfinopoulos S; Liakopoulos V; Stefanidis I
Exp Clin Transplant; 2021 Aug; 19(8):868-870. PubMed ID: 34085910
[TBL] [Abstract][Full Text] [Related]
26. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
Yang QX; Pei XJ; Tian XY; Li Y; Li Z
Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632
[TBL] [Abstract][Full Text] [Related]
27. Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA.
Delfau-Larue MH; de Leval L; Joly B; Plonquet A; Challine D; Parrens M; Delmer A; Salles G; Morschhauser F; Delarue R; Brice P; Bouabdallah R; Casasnovas O; Tilly H; Gaulard P; Haioun C
Haematologica; 2012 Oct; 97(10):1594-602. PubMed ID: 22371178
[TBL] [Abstract][Full Text] [Related]
28. Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Dunleavy K; Fanale MA; Abramson JS; Noy A; Caimi PF; Pittaluga S; Parekh S; Lacasce A; Hayslip JW; Jagadeesh D; Nagpal S; Lechowicz MJ; Gaur R; Lucas A; Melani C; Roschewski M; Steinberg SM; Jaffe ES; Kahl B; Friedberg JW; Little RF; Bartlett NL; Wilson WH
Lancet Haematol; 2018 Dec; 5(12):e609-e617. PubMed ID: 30501868
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era.
Sato A; Nakamura N; Kojima M; Ohmachi K; Carreras J; Kikuti YY; Numata H; Ohgiya D; Tazume K; Amaki J; Moriuchi M; Miyamoto M; Aoyama Y; Kawai H; Ichiki A; Hara R; Kawada H; Ogawa Y; Ando K
Cancer Sci; 2014 Sep; 105(9):1170-5. PubMed ID: 24974976
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of Factors Influencing Clinical Efficacy of Rituximab on Patients with Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma].
Zhong M; Su QH; Xu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1210-1214. PubMed ID: 32798400
[TBL] [Abstract][Full Text] [Related]
31. Aggressive Tongue Root Epstein-Barr Virus-Positive Mucocutaneous Ulcer Treated With Rituximab Alone.
Tsutsumi M; Yoshimura T; Tatsumi N; Nakaya Y; Fuseya H; Horiuchi M; Yoshida M; Hayashi Y; Nakao T; Inoue T; Yamane T
Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):e291-e294. PubMed ID: 32179033
[No Abstract] [Full Text] [Related]
32. Epstein-Barr virus-associated lymphoproliferative disease during imatinib mesylate treatment for chronic myeloid leukemia.
Yamaguchi J; Fujino T; Isa R; Nishiyama D; Kuwahara-Ota S; Kawaji Y; Tsukamoto T; Chinen Y; Shimura Y; Kobayashi T; Horiike S; Kohno K; Nakamura S; Kuroda J
Haematologica; 2019 Aug; 104(8):e376-e379. PubMed ID: 30975907
[No Abstract] [Full Text] [Related]
33. Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.
Robak T; Jin J; Pylypenko H; Verhoef G; Siritanaratkul N; Drach J; Raderer M; Mayer J; Pereira J; Tumyan G; Okamoto R; Nakahara S; Hu P; Appiani C; Nemat S; Cavalli F;
Lancet Oncol; 2018 Nov; 19(11):1449-1458. PubMed ID: 30348538
[TBL] [Abstract][Full Text] [Related]
34. [EBV-positive diffuse large B-cell lymphoma in young individual: report of a case].
Li WS; Xie JL; Zhang M; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):128-9. PubMed ID: 23710923
[No Abstract] [Full Text] [Related]
35. Methotrexate-associated lymphoproliferative disorder arising in the retromolar triangle and lung of a patient with rheumatoid arthritis.
Kudoh M; Harada H; Matsumoto K; Sato Y; Omura K; Ishii Y
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Oct; 118(4):e105-10. PubMed ID: 24811204
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr Virus-related Multi-site Mucocutaneous Ulcer: A Previously Undescribed Clinical Subset of a Rare Disease.
Schwob E; Szablewski V; Lerisson M; Dereure O
Acta Derm Venereol; 2019 Dec; 99(13):1299-1300. PubMed ID: 31408179
[No Abstract] [Full Text] [Related]
37. Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis.
Arai A; Imadome KI; Watanabe Y; Yoshimori M; Koyama T; Kawaguchi T; Nakaseko C; Fujiwara S; Miura O
Int J Hematol; 2011 May; 93(5):602-609. PubMed ID: 21491104
[TBL] [Abstract][Full Text] [Related]
38. Diffuse Large B-Cell Lymphoma Arising within Ileal Neobladder: An Expanding Spectrum of Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation.
Lee H; Shin H; Kim NY; Park HS; Park J
Cancer Res Treat; 2019 Oct; 51(4):1666-1670. PubMed ID: 30913860
[TBL] [Abstract][Full Text] [Related]
39. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy.
Ahn JS; Yang DH; Duk Choi Y; Jung SH; Yhim HY; Kwak JY; Sung Park H; Shin MG; Kim YK; Kim HJ; Lee JJ
Am J Hematol; 2013 Sep; 88(9):774-9. PubMed ID: 23760676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
